Sunday, 18 December, 2011
Dr. Philipp Baaske joins CeNS as Extraordinary Member
Philipp Baaske studied Physics at the University Bayreuth with a specialization in Biophysics. After receiving his Diploma degree in 2005 he began his PhD studies in the System Biophysics group of Prof. Dr. Dieter Braun at LMU Munich. During his studies he developed a new technology to measure the thermal stability of biomolecules "within a snapshot" and proposed a solution to the so called "concentration problem of the origin of life". His experiments with biomolecules in microthermal fields led to the development of Microscale Thermophoresis (MST), a new biophysical method for biomolecular interaction measurements. He founded the NanoTemper Technologies GmbH together with Stefan Duhr in May 2008 and finished his PhD in February 2010. With the NanoTemper team he has recently developed the label-free Microscale Thermophoresis, expanding the power of MST even further. In 2011 NanoTemper's MST is already used by hundreds of scientists worldwide and is considered as a "game changing" technology within the drug development community. Philipp Baaske is CEO of NanoTemper Technologies GmbH.